These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 17060402

  • 1. Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells.
    Rittner HL, Labuz D, Schaefer M, Mousa SA, Schulz S, Schäfer M, Stein C, Brack A.
    FASEB J; 2006 Dec; 20(14):2627-9. PubMed ID: 17060402
    [Abstract] [Full Text] [Related]

  • 2. CXCR1/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granules in vitro and in vivo.
    Rittner HL, Labuz D, Richter JF, Brack A, Schäfer M, Stein C, Mousa SA.
    Brain Behav Immun; 2007 Nov; 21(8):1021-32. PubMed ID: 17604950
    [Abstract] [Full Text] [Related]

  • 3. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells.
    Brack A, Rittner HL, Machelska H, Leder K, Mousa SA, Schäfer M, Stein C.
    Pain; 2004 Dec; 112(3):229-238. PubMed ID: 15561377
    [Abstract] [Full Text] [Related]

  • 4. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
    Catusse J, Struyf S, Wuyts A, Weyler M, Loos T, Gijsbers K, Gouwy M, Proost P, Van Damme J.
    Biochem Pharmacol; 2004 Nov 15; 68(10):1947-55. PubMed ID: 15476666
    [Abstract] [Full Text] [Related]

  • 5. Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain.
    Rittner HL, Mousa SA, Labuz D, Beschmann K, Schäfer M, Stein C, Brack A.
    J Leukoc Biol; 2006 May 15; 79(5):1022-32. PubMed ID: 16522746
    [Abstract] [Full Text] [Related]

  • 6. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
    Cummings CJ, Martin TR, Frevert CW, Quan JM, Wong VA, Mongovin SM, Hagen TR, Steinberg KP, Goodman RB.
    J Immunol; 1999 Feb 15; 162(4):2341-6. PubMed ID: 9973513
    [Abstract] [Full Text] [Related]

  • 7. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.
    Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D, Wasserman K, Oppenheim JJ.
    FASEB J; 2000 Oct 15; 14(13):2055-64. PubMed ID: 11023990
    [Abstract] [Full Text] [Related]

  • 8. The N- and C-terminal peptides of hIL8/CXCL8 are ligands for hCXCR1 and hCXCR2.
    Li QJ, Yao M, Wong W, Parpura V, Martins-Green M.
    FASEB J; 2004 Apr 15; 18(6):776-8. PubMed ID: 14766805
    [Abstract] [Full Text] [Related]

  • 9. The functional significance behind expressing two IL-8 receptor types on PMN.
    Stillie R, Farooq SM, Gordon JR, Stadnyk AW.
    J Leukoc Biol; 2009 Sep 15; 86(3):529-43. PubMed ID: 19564575
    [Abstract] [Full Text] [Related]

  • 10. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat.
    Garau A, Bertini R, Mosca M, Bizzarri C, Anacardio R, Triulzi S, Allegretti M, Ghezzi P, Villa P.
    Eur Cytokine Netw; 2006 Mar 15; 17(1):35-41. PubMed ID: 16613761
    [Abstract] [Full Text] [Related]

  • 11. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.
    Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR, Kaps C, Sittinger M.
    J Cell Biochem; 2007 May 01; 101(1):135-46. PubMed ID: 17295203
    [Abstract] [Full Text] [Related]

  • 12. Opioids and sensory nerves.
    Stein C, Zöllner C.
    Handb Exp Pharmacol; 2009 May 01; (194):495-518. PubMed ID: 19655116
    [Abstract] [Full Text] [Related]

  • 13. Recruitment of opioid peptide-containing neutrophils is independent of formyl peptide receptors.
    Hackel D, Stolz A, Mousa SA, Brack A, Rittner HL.
    J Neuroimmunol; 2011 Jan 01; 230(1-2):65-73. PubMed ID: 20869777
    [Abstract] [Full Text] [Related]

  • 14. Neurokinin-1 receptor antagonists inhibit the recruitment of opioid-containing leukocytes and impair peripheral antinociception.
    Rittner HL, Lux C, Labuz D, Mousa SA, Schäfer M, Stein C, Brack A.
    Anesthesiology; 2007 Dec 01; 107(6):1009-17. PubMed ID: 18043070
    [Abstract] [Full Text] [Related]

  • 15. The collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-alpha-PGP) does not interact directly with human CXCR1 and CXCR2.
    de Kruijf P, Lim HD, Overbeek SA, Zaman GJ, Kraneveld AD, Folkerts G, Leurs R, Smit MJ.
    Eur J Pharmacol; 2010 Sep 15; 643(1):29-33. PubMed ID: 20599927
    [Abstract] [Full Text] [Related]

  • 16. Involvement of the peripheral sensory and sympathetic nervous system in the vascular endothelial expression of ICAM-1 and the recruitment of opioid-containing immune cells to inhibit inflammatory pain.
    Mousa SA, Shaqura M, Brendl U, Al-Khrasani M, Fürst S, Schäfer M.
    Brain Behav Immun; 2010 Nov 15; 24(8):1310-23. PubMed ID: 20600813
    [Abstract] [Full Text] [Related]

  • 17. Antinociception by neutrophil-derived opioid peptides in noninflamed tissue--role of hypertonicity and the perineurium.
    Rittner HL, Hackel D, Yamdeu RS, Mousa SA, Stein C, Schäfer M, Brack A.
    Brain Behav Immun; 2009 May 15; 23(4):548-57. PubMed ID: 19233260
    [Abstract] [Full Text] [Related]

  • 18. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
    Gouwy M, Struyf S, Catusse J, Proost P, Van Damme J.
    J Leukoc Biol; 2004 Jul 15; 76(1):185-94. PubMed ID: 15075362
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-alpha.
    Asagoe K, Yamamoto K, Takahashi A, Suzuki K, Maeda A, Nohgawa M, Harakawa N, Takano K, Mukaida N, Matsushima K, Okuma M, Sasada M.
    J Immunol; 1998 May 01; 160(9):4518-25. PubMed ID: 9574558
    [Abstract] [Full Text] [Related]

  • 20. Reduced expression of chemoattractant receptors by polymorphonuclear leukocytes in Hyper IgE Syndrome patients.
    Mintz R, Garty BZ, Meshel T, Marcus N, Katanov C, Cohen-Hillel E, Ben-Baruch A.
    Immunol Lett; 2010 May 04; 130(1-2):97-106. PubMed ID: 20005258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.